Pragmatic Evidence-Based Guide to Using Chinese Herbs for Cancer Patients
Yoon Hang John Kim1*, Wendy Luo1 & Kirsten West2
1Integrative Health Program, Department of Family Medicine, University of Kansas Medical School, Kansas City, Kansas
2Naturemed Integrative Medicine, Boulder, Colorado
Dr. Yoon Hang John Kim, Integrative Health Program, Department of Family Medicine, University of Kansas Medical School, Kansas City, Kansas
Keywords: Chinese Herbs; Oncology; Acupuncture; Chemotherapy
The American Society of Clinical Oncology (ASCO) recently endorsed the use of integrative medicine in the management of breast cancer patients as proposed by the Society of Integrative Oncology (SIO). The SIO clinical guideline provides evidence-based recommendations for the use of integrative medicine during and after conventional therapies. SIO clinical practice guideline was against any use of ingested dietary supplements to manage breast cancer treatment-related adverse effects. However, in Japan, Korea, and China, there is a long history of using Chinese herbs in cancer patients with increasing evidence documenting of potential benefits. Therefore, the aim of this paper is to provide a pragmatic, evidenced based clinical guideline on how to safely use Chinese herbs in cancer patients undergoing conventional care.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).